As of 2025-06-16, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 73.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 124.39 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -40.6%.
The range of the Relative Valuation is 57.84 - 94.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 23.4x | 20.9x |
| Forward P/E multiples | 16.6x - 23.8x | 21.0x |
| Fair Price | 57.84 - 94.29 | 73.92 |
| Upside | -53.5% - -24.2% | -40.6% |
| Date | P/E |
| 2025-06-11 | 40.19 |
| 2025-06-10 | 40.38 |
| 2025-06-09 | 40.69 |
| 2025-06-06 | 40.58 |
| 2025-06-05 | 40.33 |
| 2025-06-04 | 40.30 |
| 2025-06-03 | 40.46 |
| 2025-06-02 | 40.31 |
| 2025-05-30 | 39.81 |
| 2025-05-29 | 40.02 |
| 2025-05-28 | 39.82 |
| 2025-05-27 | 39.69 |
| 2025-05-23 | 38.90 |
| 2025-05-22 | 38.55 |
| 2025-05-21 | 39.02 |
| 2025-05-20 | 39.80 |
| 2025-05-19 | 39.75 |
| 2025-05-16 | 39.17 |
| 2025-05-15 | 38.92 |
| 2025-05-14 | 38.44 |
| 2025-05-13 | 37.82 |
| 2025-05-12 | 38.98 |
| 2025-05-09 | 37.45 |
| 2025-05-08 | 38.03 |
| 2025-05-07 | 39.36 |
| 2025-05-06 | 38.49 |
| 2025-05-05 | 35.52 |
| 2025-05-02 | 35.50 |
| 2025-05-01 | 34.50 |
| 2025-04-30 | 34.85 |
| 2025-04-29 | 34.71 |
| 2025-04-28 | 34.46 |
| 2025-04-25 | 34.54 |
| 2025-04-24 | 34.23 |
| 2025-04-23 | 33.41 |
| 2025-04-22 | 32.93 |
| 2025-04-21 | 32.58 |
| 2025-04-17 | 32.81 |
| 2025-04-16 | 32.40 |
| 2025-04-15 | 31.12 |
| 2025-04-14 | 30.71 |
| 2025-04-11 | 29.41 |
| 2025-04-10 | 29.36 |
| 2025-04-09 | 30.84 |
| 2025-04-08 | 28.33 |
| 2025-04-07 | 30.18 |
| 2025-04-04 | 30.96 |
| 2025-04-03 | 33.30 |
| 2025-04-02 | 35.05 |
| 2025-04-01 | 34.63 |